Gene therapy for coronary heart disease
Open Access
- 1 November 2001
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 250 (5), 367-368
- https://doi.org/10.1046/j.1365-2796.2001.00909.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Effects of intramyocardial injection of phVEGF‐A165 as sole therapy in patients with refractory coronary artery disease – 12‐month follow‐up: Angiogenic gene therapyJournal of Internal Medicine, 2001
- Gene therapy for therapeutic angiogenesis in critically ischaemic lower limb – on the way to the clinicEuropean Journal of Clinical Investigation, 2001
- Left Ventricular Electromechanical Mapping to Assess Efficacy of phVEGF 165 Gene Transfer for Therapeutic Angiogenesis in Chronic Myocardial IschemiaCirculation, 2000
- Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 DiseaseScience, 2000
- Cardiovascular gene therapyThe Lancet, 2000
- Local Perivascular Delivery of Basic Fibroblast Growth Factor in Patients Undergoing Coronary Bypass SurgeryCirculation, 1999
- Gene therapy with vascular endothelial growth factor for inoperable coronary artery diseaseThe Annals of Thoracic Surgery, 1999
- Angiogenesis Gene TherapyCirculation, 1999
- Gene Therapy for Myocardial AngiogenesisCirculation, 1998
- Induction of Neoangiogenesis in Ischemic Myocardium by Human Growth FactorsCirculation, 1998